The title sponsor of The Mini Mile Races is Cancer Research UK Kids & Teens. Find out more about the charity and the work they are doing…

Every day around 10 young people in the UK are diagnosed with cancer. Despite improving survival rates, cancer is the leading cause of death in children, teenagers and young adults.
Cancer Research UK Kids & Teens is a campaign to raise money for research into cancers affecting children, teens and young adults. With your help we will find cures and kinder treatments for young people facing cancer.
You can do your bit when you take part in the event to find cures and kinder treatments by fundraising for Cancer Research UK Kids & Teens.


Let’s beat children’s cancers sooner

All money raised goes towards research into cancers affecting children, teens and young adults.






Why do we need your support?

  • Many children’s cancers are biologically very different from adult cancers, so finding better treatments and setting up clinical trials needs a different approach.

  • We’ve made great progress in tackling children’s cancers over the last 40 years, but survival rates across different types of cancers vary and for some children’s cancers survival rates are still far too low.

  • Treatment can have very debilitating side-effects for young people that can sadly last long into adult life, so finding kinder treatments is vital.



What progress have we made so far?

Our research into leukaemia has helped save thousands of children.  For example, we supported a trial that showed a new treatment called mitoxantrone could increase survival by more than 50% for children with acute lymphoblastic leukaemia whose cancer had come back.



We were involved in a trial that led to a dramatic improvement in survival for a type of children’s liver cancer called hepatoblastoma. Now 8 out of 10 children survive, compared to 2 out of 10 children in the 1970s.




We helped to fund ground-breaking research that changed the way that children are treated for Wilms’ tumour – a type of kidney cancer, meaning they are now less likely to experience the long-term impact of side effects including heart problems and kidney damage.